Australia's largest stock trading and investment forum Australia's #1 stock forum

ODA

2.70%

18.0¢ orcoda limited

it's valued at $50m when it makes $1m a year in profit

First 6 Last

Share
Profile

Follow
Pooslice

2,479 Posts.

274

25/05/23

19:19

Post #: 67967416
Share

Originally posted by AC88: ↑

I think roll out is the operative word here...I have been tracking this for a while and they don't do MOU's with non-recognizable foreign firms...these guys have genuinely large and well credentialed counterparties and clients.....Teletrac Navman are well renowned hard taskmasters..
i think this is on 2 x current rev, strongly operationally positive...and they are heading into their seasonally strongest period, its hard to find stocks like this.

Expand

it's valued at $50m when it makes $1m a year in profit

ODA Price at posting: 30.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 4 more messages in this thread...

First 6 Last

Add ODA (ASX) to my watchlist

(20min delay)
Last 18.0¢		Change -0.005(2.70%)		Mkt cap ! $30.44M

Open	High	Low	Value	Volume
18.0¢	18.0¢	18.0¢	$1	3

Buyers (Bids)

No.	Vol.	Price($)
1	32500	14.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.5¢	3	1

View Market Depth

No.	Vol.	Price($)
1	32500	0.145
1	30000	0.140
1	2000	0.130
1	60000	0.050
0	0	0.000

Price($)	Vol.	No.
0.175	3	1
0.180	95997	1
0.195	2330	1
0.200	66618	3
0.210	50000	1

Last trade - 11.14am 04/10/2024 (20 minute delay)

ODA (ASX) Chart

it's valued at $50m when it makes $1m a year in profit

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

it&apos;s valued at $50m when it makes $1m a year in profit

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

it's valued at $50m when it makes $1m a year in profit